# First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis

> **NCT02236975** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sino Medical Sciences Technology Inc.** · enrollment: 168 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** BuMA Supreme Biodegradable drug coating coronary stent system
- **DEVICE:** Resolute Integrity durable polymer stent system

## Key facts

- **NCT ID:** NCT02236975
- **Lead sponsor:** Sino Medical Sciences Technology Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-11
- **Final completion:** 2019-03
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2020-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236975, "First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02236975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*